The National Institutes of Health is offering a grant to support the optimization of monoclonal antibodies or their derivatives aimed at targeting and eliminating HIV reservoir cells. Applications are encouraged to advance research in combating HIV infection and reducing the viral reservoir. Closing date: January 9, 2019.
Opportunity ID: 281805
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-16-115 |
| Funding Opportunity Title: | Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 25, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 09, 2019 |
| Current Closing Date for Applications: | Jan 09, 2019 |
| Archive Date: | Feb 09, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Independent school districts Special district governments Native American tribal governments (Federally recognized) State governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Private institutions of higher education City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages applications to support the optimization of monoclonal antibodies (mAb) or mAb derivatives that recognize and eliminate cells comprising the HIV reservoir. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-16-115.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00224308 | Dec 10, 2016 | Jan 24, 2018 | View | |
| FORMS-C | FORMS-C | PKG00221189 | Apr 16, 2016 | Jun 14, 2016 | View | |
| FORMS-E | Use for due dates on or after January 25, 2018 | PKG00235788 | Nov 06, 2017 | Jan 09, 2019 | View |
Package 1
Mandatory forms
281805 RR_SF424_2_0-2.0.pdf
281805 PHS398_CoverPageSupplement_3_0-3.0.pdf
281805 RR_OtherProjectInfo_1_3-1.3.pdf
281805 PerformanceSite_2_0-2.0.pdf
281805 RR_KeyPersonExpanded_2_0-2.0.pdf
281805 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
281805 RR_Budget_1_3-1.3.pdf
281805 RR_SubawardBudget30_1_3-1.3.pdf
281805 PHS398_ModularBudget_1_2-1.2.pdf
281805 PHS_Inclusion_Enrollment_Report-1.0.pdf
281805 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
281805 RR_SF424_2_0-2.0.pdf
281805 PHS398_ResearchPlan_2_0-2.0.pdf
281805 PHS398_CoverPageSupplement_2_0-2.0.pdf
281805 RR_KeyPersonExpanded_2_0-2.0.pdf
281805 RR_OtherProjectInfo_1_3-1.3.pdf
281805 PerformanceSite_2_0-2.0.pdf
Optional forms
281805 RR_SubawardBudget30_1_3-1.3.pdf
281805 PlannedReport-1.0.pdf
281805 PHS398_CumulativeInclusionReport-1.0.pdf
281805 PHS398_ModularBudget_1_2-1.2.pdf
281805 RR_Budget_1_3-1.3.pdf
Package 3
Mandatory forms
281805 RR_SF424_2_0-2.0.pdf
281805 PHS398_CoverPageSupplement_4_0-4.0.pdf
281805 RR_OtherProjectInfo_1_4-1.4.pdf
281805 PerformanceSite_2_0-2.0.pdf
281805 RR_KeyPersonExpanded_2_0-2.0.pdf
281805 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
281805 RR_Budget_1_4-1.4.pdf
281805 RR_SubawardBudget30_1_4-1.4.pdf
281805 PHS398_ModularBudget_1_2-1.2.pdf
281805 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
